John Dobak - Mar 25, 2022 Form 4 Insider Report for DermTech, Inc. (DMTK)

Role: Chief Executive Officer, Director
Signature: /s/ Jason S. Miller, attorney-in-fact
Stock symbol: DMTK
Transactions as of: Mar 25, 2022
Transactions value $: $0
Form type: 4
Date filed: 3/25/2022, 08:10 PM
Previous filing: Mar 15, 2022
Next filing: May 31, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DMTK	Common Stock	Award	$0	+210K	+46.92%	$0.00	656K	Mar 25, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. Subject to the reporting person's continued service, (i) twelve thirty-sixths (12/36) of the restricted stock units shall vest on March 5, 2023 and (ii) the remaining twenty-four thirty-sixths (24/36) shall vest in eight (8) equal installments of three thirty-sixths (3/36) on the fifth day of each third month following March 5, 2023 until the final vesting date on March 5, 2025.

Content

The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. Subject to the reporting person's continued service, (i) twelve thirty-sixths (12/36) of the restricted stock units shall vest on March 5, 2023 and (ii) the remaining twenty-four thirty-sixths (24/36) shall vest in eight (8) equal installments of three thirty-sixths (3/36) on the fifth day of each third month following March 5, 2023 until the final vesting date on March 5, 2025.